| Ticker Details |
Pacira BioSciences, Inc.
Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.
|
| IPO Date: |
February 3, 2011 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$954.34M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.85 | 2.08%
|
| Avg Daily Range (30 D): |
$0.51 | 2.36%
|
| Avg Daily Range (90 D): |
$0.46 | 2.03%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
.72M |
| Avg Daily Volume (90 D): |
.61M |
| Trade Size |
| Avg Trade Size (Sh.): |
84 |
| Avg Trade Size (Sh.) (30 D): |
52 |
| Avg Trade Size (Sh.) (90 D): |
50 |
| Institutional Trades |
| Total Institutional Trades: |
8,937 |
| Avg Institutional Trade: |
$1.78M |
| Avg Institutional Trade (30 D): |
$1.99M |
| Avg Institutional Trade (90 D): |
$2.12M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.34M |
| Avg Closing Trade (30 D): |
$2.31M |
| Avg Closing Trade (90 D): |
$2.7M |
| Avg Closing Volume: |
61.41K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.12
|
$-.11
|
|
Diluted EPS
|
|
$.12
|
$-.11
|
|
Revenue
|
|
$179.52M
|
$181.1M
|
|
Gross Profit
|
|
$145.24M
|
$140.23M
|
|
Net Income / Loss
|
|
$5.43M
|
$-4.85M
|
|
Operating Income / Loss
|
|
$6.36M
|
$8.5M
|
|
Cost of Revenue
|
|
$34.28M
|
$40.87M
|
|
Net Cash Flow
|
|
$-152.9M
|
$16.87M
|
|
PE Ratio
|
|
|
|
|
|
|
